I am not denying the complexity or the potential risks, but I also believe that this is the kind of information people should understand, and can take to a gene

I am not denying the complexity or the potential risks, but I also believe that this is the kind of information people should understand, and can take to a genetic counselor and discuss. The information is well curated, updated, you get your raw data. I would insist on that policy. Genetic information in it's individuality is of no use. With a large enough pool with associated traits, it's ideal for research and that's why they have it. I live in this world and yes, the data are complex, but there are some very smart people working on making this more accessible (including at 23andme). If we want people to be curious about genetics, make an effort to understand the information, and also understand the implications, if a commercial entity comes along to give this a shot in the arm, it's a good thing. If it's too early, the market will make that decision.